Getting it Wrong: Are We Missing the Most Critical Point When it Comes to Achieving Clinical Trial Diversity?
There is a growing need to refocus efforts on how diversity is achieved in clinical trials, because some are doing it wrong despite their best intentions.
Politically Incorrect Diversity in Clinical Trials
Some actions to consider for your next trial or submission.
Informed Consent: Observations and Response to the FDA's Draft Guidance of July 2014
It should suffice to say that obtaining informed consent is required ethically and legally in almost all forms of human research in almost all countries.
DIY EDC Evaluation
Options have emerged that make DIY EDC technology more accessible to smaller organizations.
Risk-based Approach to Monitoring
While risk and uncertainty remain high, the pace of innovation will remain glacial.
When is EDC not ePRO?
An Applied Clinical Trials Editorial Advisory Member gives his opinion on where the differences lie between EDC and ePRO systems.
EDC: Caught in a Trap
Some starry-eyed vendors can't turn their back on older technology because they're too attached.
Data Management: R.I.P. or Brave New World?
As more companies adopt eClinical technologies, data managers must redefine and update their role.
The CTMS Story: Focusing on Need
A story about 1/2-inch holes and the power of liquid soap
Do More with Less: The New eRO Model
Clinical departments are very expensive to run and maintain.